Correction: Biosimilar recombinant follitropin alfa preparations versus the reference product (Gonal-F®) in couples undergoing assisted reproductive technology treatment: a systematic review and meta-analysis

• Christos A. Venetis,
• Christoph Helwig,
• Ben W. Mol,
• Su Jen Chua,
• Salvatore Longobardi,
• Raoul Orvieto,
• Monica Lispi,
• Ashleigh Storr,
• Thomas D’Hooghe

Affiliations

Christos A. Venetis

Unit for Human Reproduction, 1st Dept of OB/Gyn, Faculty of Medicine, School of Health Sciences, Aristotle University of Thessaloniki

Christoph Helwig

Global Biostatistics, Merck KGaA

Ben W. Mol

Department of Obstetrics and Gynecology, University of Monash

Su Jen Chua

Alfred Health

Salvatore Longobardi

Global Clinical Development, Merck Serono S.p.A (an affiliate of Merck KGaA, Darmstadt 64293, Germany)

Raoul Orvieto

Department of Obstetrics and Gynecology, Chaim Sheba Medical Center, Tel-Hashomer

Monica Lispi

University of Modena and Reggio Emilia

Ashleigh Storr

Flinders Fertility

Thomas D’Hooghe

GlobalMedical Affairs Fertility, Research and Development